Texas Attorney General Ken Paxton sued Pfizer, alleging the Big Pharma giant lied about the effectiveness of its COVID-19 vaccine.1 In addition to misrepresenting the shot’s efficacy, the suit claims Pfizer attempted to censor public discussion related to the shot. “Pfizer engaged in false, deceptive and misleading acts and practices by making unsupported claims regarding… Read More »
Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of October—and that an FDA application could soon follow. But more than 60 researchers and bioethicists urged the partners to wait for more safety data before submitting their shot for a green light, Bloomberg reports. The experts called on… Read More »
Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange. Drew Angerer | Getty Images Pfizer CEO Albert Bourla warned on Tuesday that people who don’t take the Covid-19 vaccine will become a “weak link” that allows the coronavirus to spread. Bourla, whose company is in… Read More »
The J.P. Morgan Healthcare Conference may be over, but that doesn’t mean the dealmaking is. Often, deals that took shape at the meeting materialize later in the year, and some recent buzz puts Pfizer and Biogen at the center of potential takeovers. Pfizer is reportedly eyeing a buyout of cardiovascular player Amarin, whose fish-oil-derived lipid drug… Read More »
Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »